Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

Unlocking the potential of vaccines built on messenger RNA

The technology could help to boost immunity against cancer, influenza and much more.
  1. Elie Dolgin

    1. Elie Dolgin is a science journalist in Somerville, Massachusetts.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Brad Kremer received an experimental vaccine for his cancer. Credit: Katye Martens Brier

Brad Kremer had waited months to receive an experimental cancer vaccine called BNT122, during which time the melanoma on his skin had spread to his liver and spine. His back pain was getting worse, he was rapidly losing weight and new cancerous lesions kept appearing on his left thigh. “It was very scary,” says Kremer, a 52-year-old sales representative from Acton, Massachusetts.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 574, S10-S12 (2019)

doi: https://doi.org/10.1038/d41586-019-03072-8

This article is part of Nature Outlook: RNA therapy, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Sahin, U. et al. Nature 547, 222–226 (2017).

    Article  PubMed  Google Scholar 

  2. Alberer, M. et al. Lancet 390, 1511–1520 (2017).

    Article  PubMed  Google Scholar 

  3. Feldman, R. A. et al. Vaccine 37, 3326–3334 (2019).

    Article  PubMed  Google Scholar 

  4. John, S. et al. Vaccine 36, 1689–1699 (2018).

    Article  PubMed  Google Scholar 

  5. Hekele, A. et al. Emerg. Microb. Infect. 2, e52 (2013).

    Article  Google Scholar 

  6. Baeza Garcia, A. et al. Nature Commun. 9, 2714 (2018).

    Article  PubMed  Google Scholar 

  7. Lutz, J. et al. npj Vaccines 2, 29 (2017).

    Article  PubMed  Google Scholar 

  8. Vogel, A. B. et al. Mol. Ther. 26, 446–455 (2018).

    Article  PubMed  Google Scholar 

  9. Hattinger, E. et al. J. Immunol. Res. 2015, 797421 (2015).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links